Aptevo Therapeutics Inc. (APVO) NASDAQ

$4 (0.06) (-1.48%)

Market Cap: $95.30M

As of 03/28/24 12:18 PM EDT. Market open.

(APVO)

Aptevo Therapeutics Inc. (APVO)
NASDAQ

$4
(0.06) (-1.48%)

Market Cap: $95.30M

As of 03/28/24 12:18 PM EDT. Market open.

Add to Portfolio

aptevo therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. we leverage the innovative adaptir™ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients. based in seattle, washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary ... read more

aptevo therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. we leverage the innovative adaptir™ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients. based in seattle, washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary platform technology. as a result, aptevo has been able to attract some of the most innovative minds in the field. many of our team members have notable experience with other pioneering biotech companies including trubion, zymogenetics, immunex, dendreon, and vlst. at aptevo therapeutics, our core values of ownership and collaboration—combined with a history of innovation, dedication, and development—are positioning aptevo therapeutics to develop the science of what’s next in biotechnology. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO Compensation (Base)
$543,387
CEO Compensation (Total)
$1.05M
URL
Address
2401 4th Ave Ste 1050, Washington, Seattle, 98121-3460.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
59
CEO Compensation (Base)
$543,387
CEO Compensation (Total)
$1.05M
Address
2401 4th Ave Ste 1050, Washington, Seattle, 98121-3460.
PRICE CHART FOR APTEVO THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$4.20
Previous Close
$4.06
Days Range
$3.91 - $4.08
52 week range
$3.81 - $92.62
Volume
117,652
Avg. Volume (30 days)
278,945
Market Cap
$95.30M
Dividend Yield
-
P/E
-
Shares Outstanding
23,472,436
Open
$4.20
Previous Close
$4.06
Days Range
$3.91 - $4.08
52 week range
$3.81 - $92.62
Volume
117,652
Avg. Volume (30 days)
278,945
Market Cap
$95.30M
Dividend Yield
-
P/E
-
Shares Outstanding
23,472,436
FINANCIAL STATEMENTS FOR APTEVO THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR APTEVO THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Niederhuber JohnDirectorJun 14, 2019 Buy$0.917146501,516Jun 03, 2022, 03:06 PM
TANG KEVIN CExit FilingNov 23, 2021 Sale$11.25921,33610,368,236760,000Nov 26, 2021, 01:02 PM
TANG KEVIN C10% OwnerNov 22, 2021 Sale$7.03255,3311,795,9871,160,000Nov 22, 2021, 05:26 PM
TANG KEVIN C10% OwnerNov 19, 2021 Sale$7.59213,8001,622,8671,360,000Nov 22, 2021, 05:26 PM
TANG KEVIN C10% OwnerNov 18, 2021 Sale$8.34369,5333,081,5571,716,787Nov 22, 2021, 05:26 PM
TANG KEVIN C10% OwnerNov 06, 2020 Buy$22.73174,2773,961,8981,760,000Nov 06, 2020, 04:47 PM
TANG KEVIN C10% OwnerNov 05, 2020 Buy$18.78625,72311,750,3071,585,723Nov 06, 2020, 04:47 PM
TANG KEVIN C10% OwnerNov 04, 2020 Buy$14.35636,6759,137,026960,000Nov 06, 2020, 04:47 PM
Maddux Randy JoeSVP Operations, CMOAug 16, 2019 Buy$0.7625,00019,00075,000Aug 19, 2019, 08:29 AM
El-Hibri FuadDirectorAug 12, 2019 Buy$0.76100,00075,5201,124,536Aug 13, 2019, 09:46 PM
El-Hibri FuadDirectorJul 29, 2019 Buy$0.8355,01545,8611,024,536Jul 30, 2019, 06:49 PM
El-Hibri FuadDirectorJul 23, 2019 Buy$0.9010,0008,996969,521Jul 24, 2019, 06:49 PM
El-Hibri FuadDirectorJul 22, 2019 Buy$0.8930,00026,601959,521Jul 23, 2019, 04:19 PM
El-Hibri FuadDirectorJul 19, 2019 Buy$0.9026,46023,740929,521Jul 19, 2019, 06:18 PM
El-Hibri FuadDirectorJul 18, 2019 Buy$0.8714,40412,596903,061Jul 18, 2019, 05:12 PM
El-Hibri FuadDirectorJul 17, 2019 Buy$0.8719,13616,704888,657Jul 18, 2019, 04:50 PM
El-Hibri FuadDirectorJul 16, 2019 Buy$0.8511,3759,662869,521Jul 16, 2019, 05:54 PM
El-Hibri FuadDirectorJul 11, 2019 Buy$0.8514,69112,454858,146Jul 12, 2019, 12:41 PM
El-Hibri FuadDirectorJul 10, 2019 Buy$0.8518,91916,058843,455Jul 11, 2019, 04:10 PM
Abdun-Nabi DanielDirectorJun 25, 2019 Buy$0.9016,66715,000109,351Jun 25, 2019, 07:11 PM
White Marvin LPresident and CEOJun 14, 2019 Buy$0.8850,00044,000293,603Jun 14, 2019, 01:58 PM
Kunz Barbara LopezDirectorJun 10, 2019 Buy$0.8510,0008,48110,000Jun 11, 2019, 02:57 PM
Harsanyi ZsoltDirectorJun 07, 2019 Buy$0.7850,00039,00050,000Jun 07, 2019, 03:19 PM
Maddux Randy JoeSenior VP, OperationsMay 31, 2019 Buy$0.7320,00014,60050,000Jun 07, 2019, 03:18 PM
Grant Grady IIIDirectorMay 21, 2019 Buy$0.8010,0007,97010,000May 21, 2019, 06:12 PM
White Marvin LPresident and CEOMay 20, 2019 Buy$0.8130,00024,300243,603May 20, 2019, 07:22 PM
White Marvin LPresident and CEOMay 14, 2019 Buy$0.7810,0007,800213,603May 14, 2019, 09:27 PM
Stromatt Scott CChief Medical Officer and SVPMar 01, 2019 Option Exercise$1.574,8237,572216,183Mar 04, 2019, 09:09 PM
Mitchell ShawnteSVP, GC and Corporate AffairsMar 01, 2019 Option Exercise$1.572,0123,15980,527Mar 04, 2019, 09:08 PM
Lamothe Jeffrey G.SVP and CFOMar 01, 2019 Option Exercise$1.572,1703,40775,024Mar 04, 2019, 09:05 PM
Gross Jane ASee RemarksMar 01, 2019 Option Exercise$1.572,7104,255109,583Mar 04, 2019, 09:04 PM
Adelman MichaelSVP, Commercial OperationsMar 01, 2019 Option Exercise$1.572,3953,76070,426Mar 04, 2019, 09:03 PM
Maddux Randy JoeSVP OperationsDec 06, 2018 Buy$2.375,00011,85030,000Dec 07, 2018, 06:28 PM
White Marvin LPresident and CEODec 04, 2018 Buy$2.3810,00023,800203,603Dec 06, 2018, 10:23 AM
Mitchell ShawnteSVP, GC and Corporate AffairsAug 09, 2018 Option Exercise$4.503831,72475,752Aug 13, 2018, 04:45 PM
White Marvin LPresident and CEOMay 21, 2018 Option Exercise$5.618,37346,973193,603May 23, 2018, 04:08 PM
White Marvin LPresident and CEOMar 19, 2018 Buy$2.93100,000293,000166,332Mar 21, 2018, 03:15 PM
White Marvin LPresident and CEOMar 19, 2018 Sale$2.93100,000293,000166,332Mar 21, 2018, 11:57 AM
Lamothe Jeffrey G.SVP, CFO and TreasurerMar 10, 2018 Option Exercise$3.131,5834,95569,876Mar 13, 2018, 09:37 PM
Gross Jane ASee RemarksMar 09, 2018 Option Exercise$3.132,2827,143103,155Mar 13, 2018, 09:36 PM
Lamothe Jeffrey G.SVP, CFO and TreasurerMar 01, 2018 Option Exercise$3.041,7175,22064,712Mar 05, 2018, 07:38 PM
Lamothe Jeffrey G.SVP, CFO and TreasurerFeb 03, 2018 Option Exercise$3.247,51424,34559,109Feb 06, 2018, 07:21 PM
Maddux Randy JoeSenior VP, OperationsNov 15, 2017 Buy$2.7625,00069,00025,000Dec 08, 2017, 06:06 PM
Gross Jane ASee RemarksAug 01, 2017 Option Exercise$1.8310,07618,43968,433Aug 03, 2017, 03:59 PM
Gross Jane ASee RemarksMar 10, 2017 Option Exercise$1.783,8376,83040,416Mar 13, 2017, 09:06 PM
Gross Jane ASee RemarksMar 09, 2017 Option Exercise$1.802,5734,63129,747Mar 13, 2017, 09:06 PM
Gross Jane ASee RemarksMar 01, 2017 Option Exercise$2.022,1484,33922,593Mar 13, 2017, 09:06 PM
Lamothe Jeffrey G.SVP, CFO and TreasurerMar 10, 2017 Option Exercise$1.786,77512,05941,284Mar 13, 2017, 09:05 PM
Lamothe Jeffrey G.SVP, CFO and TreasurerMar 01, 2017 Option Exercise$2.021,9363,91122,450Mar 13, 2017, 09:05 PM
Stromatt Scott CChief Medical Officer and SVPMar 10, 2017 Option Exercise$1.786,57011,69569,072Mar 13, 2017, 09:05 PM
Stromatt Scott CChief Medical Officer and SVPMar 09, 2017 Option Exercise$1.803,6786,62050,806Mar 13, 2017, 09:05 PM
Stromatt Scott CChief Medical Officer and SVPMar 01, 2017 Option Exercise$2.025,31210,73040,582Mar 13, 2017, 09:05 PM
Lamothe Jeffrey G.SVP, CFO and TreasurerFeb 03, 2017 Option Exercise$1.928,27415,88617,066Feb 08, 2017, 06:28 PM
Gross Jane ASee RemarksFeb 03, 2017 Option Exercise$1.925,92211,37015,871Feb 08, 2017, 06:26 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Niederhuber JohnDirector06/14/2019650
TANG KEVIN CExit Filing11/23/202110,368,236
TANG KEVIN C10% Owner11/22/20211,795,987
TANG KEVIN C10% Owner11/19/20211,622,867
TANG KEVIN C10% Owner11/18/20213,081,557
TANG KEVIN C10% Owner11/06/20203,961,898
TANG KEVIN C10% Owner11/05/202011,750,307
TANG KEVIN C10% Owner11/04/20209,137,026
Maddux Randy JoeSVP Operations, CMO08/16/201919,000
El-Hibri FuadDirector08/12/201975,520
El-Hibri FuadDirector07/29/201945,861
El-Hibri FuadDirector07/23/20198,996
El-Hibri FuadDirector07/22/201926,601
El-Hibri FuadDirector07/19/201923,740
El-Hibri FuadDirector07/18/201912,596
El-Hibri FuadDirector07/17/201916,704
El-Hibri FuadDirector07/16/20199,662
El-Hibri FuadDirector07/11/201912,454
El-Hibri FuadDirector07/10/201916,058
Abdun-Nabi DanielDirector06/25/201915,000
White Marvin LPresident and CEO06/14/201944,000
Kunz Barbara LopezDirector06/10/20198,481
Harsanyi ZsoltDirector06/07/201939,000
Maddux Randy JoeSenior VP, Operations05/31/201914,600
Grant Grady IIIDirector05/21/20197,970
White Marvin LPresident and CEO05/20/201924,300
White Marvin LPresident and CEO05/14/20197,800
Stromatt Scott CChief Medical Officer and SVP03/01/20197,572
Mitchell ShawnteSVP, GC and Corporate Affairs03/01/20193,159
Lamothe Jeffrey G.SVP and CFO03/01/20193,407
Gross Jane ASee Remarks03/01/20194,255
Adelman MichaelSVP, Commercial Operations03/01/20193,760
Maddux Randy JoeSVP Operations12/06/201811,850
White Marvin LPresident and CEO12/04/201823,800
Mitchell ShawnteSVP, GC and Corporate Affairs08/09/20181,724
White Marvin LPresident and CEO05/21/201846,973
White Marvin LPresident and CEO03/19/2018293,000
White Marvin LPresident and CEO03/19/2018293,000
Lamothe Jeffrey G.SVP, CFO and Treasurer03/10/20184,955
Gross Jane ASee Remarks03/09/20187,143
Lamothe Jeffrey G.SVP, CFO and Treasurer03/01/20185,220
Lamothe Jeffrey G.SVP, CFO and Treasurer02/03/201824,345
Maddux Randy JoeSenior VP, Operations11/15/201769,000
Gross Jane ASee Remarks08/01/201718,439
Gross Jane ASee Remarks03/10/20176,830
Gross Jane ASee Remarks03/09/20174,631
Gross Jane ASee Remarks03/01/20174,339
Lamothe Jeffrey G.SVP, CFO and Treasurer03/10/201712,059
Lamothe Jeffrey G.SVP, CFO and Treasurer03/01/20173,911
Stromatt Scott CChief Medical Officer and SVP03/10/201711,695
Stromatt Scott CChief Medical Officer and SVP03/09/20176,620
Stromatt Scott CChief Medical Officer and SVP03/01/201710,730
Lamothe Jeffrey G.SVP, CFO and Treasurer02/03/201715,886
Gross Jane ASee Remarks02/03/201711,370
Load More Insider Transactions
FUNDS WITH A POSITION IN APTEVO THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
RENAISSANCE TECHNOLOGIES LLC516,7890.00015%193.66%Other
GEODE CAPITAL MANAGEMENT, LLC43,2010%-42.67%Other
BLACKROCK INC.46,6350%-2.17%Other
BUYBACK ANNOUNCEMENT(S) FOR APTEVO THERAPEUTICS INC
LOADING...